NCT04302051Withdrawn
Assessment of Fatty Liver With Thermo-acoustic Device
Feasibility Study for Quantifying Fatty Liver Using Thermo-acoustic Imaging
Source: ClinicalTrials.gov · Last updated 10 Jul 2026
Reason given: The sponsor withdrew from the study
Brief summary (registry, in English)
The study will evaluate the accuracy of hepatic steatosis estimation by thermo-acoustic ultrasound with estimation by MRI-PDFF (Proton Density Fat Fraction) . It will also evaluate the sensitivity of this device in the diagnosis of fatty liver.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 6 Mar 2020
- Start date
- 2 Nov 2023
- Primary completion date
- 9 Jul 2026
- Lead sponsor
- Medical College of Wisconsin
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT04302051
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- any metal or electronic implants including but not limited to pacemakers, clips, hips
Other illness
- known history of pregnancy or becoming pregnant during study period
Other
- unable to understand and sign on written informed consent
- intolerant to ultrasound and/or MRI examinations
Who the study is looking for
- patients diagnosed or suspected to have non-alcoholic fatty liver disease
- Patients 18-70 years of age
- be able to understand and sign on written informed consent
- able to undergo ultrasound and MRI examinations
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Froedtert Hospital | Milwaukee | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.